ArticleArthroplasty today2026
Culture-Specific Outcomes of Intra-Articular Antibiotic Infusion With Implant-Retaining Debridement for Periprosthetic Joint Infection After Unicompartmental Knee Arthroplasty.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Periprosthetic joint infection (PJI) following unicompartmental knee arthroplasty (UKA) poses a substantial therapeutic challenge, particularly in culture-negative cases. The efficacy of debridement, antibiotics, and implant retention (DAIR) for PJI after UKA remains inadequately defined. This study evaluated DAIR supplemented by postoperative catheter-based intra-articular antibiotic infusion and compared outcomes between culture-positive and culture-negative patients. Methods: In this single-center retrospective cohort study, 21 patients with PJI after UKA who met the 2018 International Consensus Meeting criteria were treated with DAIR, including radical debridement, povidone-iodine lavage, and postoperative catheter-based intra-articular antibiotic infusion. The primary outcome was eradication success at 2 years. Secondary outcomes included reoperation, functional recovery, inflammatory-marker normalization, and antibiotic-related complications. Results: At a mean follow-up of 25 months, the overall infection eradication rate was 85.7%, with no significant difference between culture-positive (83.3%) and culture-negative (88.9%) groups. Functional scores improved substantially and comparably between groups. However, culture-negative patients experienced significantly longer hospital stays (18.2 vs 13.7 days, Conclusions: In this exploratory single-center cohort, DAIR supplemented by catheter-based intra-articular antibiotic infusion demonstrated encouraging mid-term infection control in carefully selected patients with UKA-PJI. Comparable infection-control and functional outcomes were observed between culture-positive and culture-negative cases; however, the limited sample size precludes definitive conclusions regarding equivalence between groups. Level of Evidence: Therapeutic Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.